What Is DSPE-PEG?
DSPE-PEG, short for 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)], is a synthetic phospholipid that is widely utilized in various pharmaceutical and biomedical applications due to its unique properties.
Structure and Properties of DSPE-PEG
DSPE-PEG a synthetic amphiphilic molecule consisting of a phospholid(DSPE) and a polyethylene glycol (PEG) chain. The DSPE component provides the hydrophobic "tail," while the PEG portion serves as biocompatible hydrophilic "head." This unique structure gives DSPE-PEG excellent biocompatibility and amphipathic properties, making it suitable for forming stable liposome nanoparticles in aqueous environments.
The PEGylation of DSPE imparts several advantageous properties to the resulting block copolymers. Notably, PEGylation enhances the solubility of DSPE-PEG aqueous media, reduces nonspecific protein binding, prolongs circulation time in the bloodstream, and improves biocompatibility. Additionally, the terminal groups of DSPE-PEG can be readily activated and modified with ligands, enabling targeted drug delivery applications.
- Key Effects of Molecular Weight
Chemical structure of DSPE-PEG. [1]
The molecular weight of DSPE-PEG, specifically the length of the polyethylene glycol (PEG) chain attached to the DSPE moiety, can have significant effects on its properties and functionalities. Some key effects of DSPE-PEG molecular weight include:
- Solubility
- Stability
- Circulation Half-Life
- Biocompatibility
- Drug Delivery
- Cellular Uptake
Quick Selection List for DSPE-PEG
DSPE-PEG Terminal Derivatives
DSPE-PEG derivatives encompass various terminal modifications that further enhance the functionality of this polymer in biomedical applications. The terminal derivatives of DSPE-PEG include:
- Amine-terminated DSPE-PEG
This derivative has an amine group at its terminal end, allowing for further conjugation with molecules containing carboxylic acid groups or other suitable reactive functional groups.
Amino-PEG-DSPE. [1]
- Carboxylic acid-terminated DSPE-PEG
In this derivative, the terminal end is a carboxylic acid group, which facilitates conjugation with molecules containing amino groups via peptide coupling or other bioconjugation chemistry.
- Thiol-terminated DSPE-PEG
This derivative terminates with a thiol group, offering the potential for thiol-specific conjugation reactions, such as thiol-maleimide chemistry, forming stable covalent linkages with maleimide-functionalized molecules.
Hydroxyl-terminated DSPE-PEG
This derivative ends with a hydroxyl group, which can serve as an attachment point for various chemical modifications, such as esterification or etherification reactions.
- Activated ester-terminated DSPE-PEG
The terminal end of this derivative contains an activated ester group, enabling facile conjugation with amine-containing molecules through nucleophilic substitution reactions.
- Maleimide-terminated DSPE-PEG
This derivative features a maleimide group as its terminal end, suitable for selective and stable conjugation with thiols through Michael addition reactions.
Mal-PEG-SC. [1]
DSPE-PEG for Vaccines Development
DSPE-PEG, due to its unique properties and functionalities, finds several applications in vaccine development and delivery. Here are the key applications of DSPE-PEG in vaccines:
DSPE-PEG can be utilized to improve the stability of vaccine formulations. The PEG moiety provides steric hindrance and shields vaccine antigens or adjuvants from aggregation, enzymatic degradation, and physical or chemical instability, thereby extending the shelf-life of the vaccines.
- Prolonged Circulation Half-Life
Incorporating DSPE-PEG into vaccine formulations can extend the circulation half-life of antigens or adjuvants in the bloodstream.
DSPE-PEG can be engineered to enable targeted delivery of vaccine components to specific cells or tissues.
DSPE-PEG can serve as a carrier for adjuvants, such as Toll-like receptor (TLR) agonists, enhancing their stability and enabling controlled release at the site of vaccination.
- Modulation of Immune Response
By tuning the properties of DSPE-PEG-based vaccine carriers, it is possible to bias the immune response towards desired T-helper (Th) cell subsets, promoting either humoral (Th2-biased) or cellular (Th1-biased) immunity, as needed for specific vaccines.
References
- Dimitrios Bitounis, et al. International Scholarly Research Notices, 2012, 738432.
- Rongrong Wang, et al. International journal of nanomedicine, 2012, 7, 4185-4198.
- Che, Jing, et al. Current pharmaceutical design, 2015, 21(12), 1598-1605.
Our products and services are for research use only and cannot be used for any clinical purposes.